Ibrutinib as a treatment of hematologic autoimmune disorders in patients with indolent B‐cell lymphoma. - Daniel, Adrien; Ghez, David; Ravaiau, Camille; Cavalieri, Doriane; Tournilhac, Olivier; Herbaux, Charles; Roriz, Mélanie; Wemeau, Mathieu; Guillet, Stéphanie; Bossard, Jean Baptiste; Hélène, Demarquette; Kaphan, Eleonore; et al. (European Journal of Haematology, 2022)